28595-805 : Histex 1.25 mg Oral Tablet, Chewable
NDC: | 28595-805 |
Labeler: | Allegis Pharmaceuticals, LLC |
Product Type: | Human OTC Drug |
Drug Name: | ![]() |
Dosage Form: | Oral Tablet, Chewable |
Application #: | part341 |
Rev. Date: |
Appearance:
Markings: | 805 |
Shapes: |
Round |
Colors: |
![]() |
Size (mm): | 9 |
Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. |
NDC Package Codes:
- 28595-805-60: 60 TABLET, CHEWABLE IN 1 BOTTLE (28595‑805‑60)
Active Ingredients:
- Triprolidine Hydrochloride
Dosage Strength:
- 1.25 mg
Inactive Ingredients:
- Magnesium Stearate
- Microcrystalline Cellulose
- Sodium Starch Glycolate Type a Potato
- Sucralose
- Xylitol
Related Products:
Based on records with the same trade name.- 28595-802 Histex 2.5 mg/5ml Oral Syrup by Allegis Pharmaceuticals, LLC
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 28595-804Next: 28595-808 >
Related Discussions:
Triprolidine And Pseudoephedrine
is pseudoephedrine 60mg with triopolidine 2.5mg a banned drug in india ## No, from what I am finding listed, it is avail... 3 replies
is pseudoephedrine 60mg with triopolidine 2.5mg a banned drug in india ## No, from what I am finding listed, it is avail... 3 replies
Pseudoephedrine 60mg Triprolidine 2.5mg
want to know the indian company which are the largest manufacturer of this composition ## i am requiring tablet with the... 6 replies
want to know the indian company which are the largest manufacturer of this composition ## i am requiring tablet with the... 6 replies
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.